The NIH All of Us Research Program has awarded $4.6 million in initial funding to Color, a health technology company in Burlingame, CA, to establish the program’s nationwide genetic counseling resource. With the goal of speeding up health research breakthroughs, All of Us plans to sequence the genomes of 1 million participants from diverse communities across the United States. Through this funding, Color’s network of genetic counselors will help participants understand what the genomic testing results mean for their health and their families. As one of the most ambitious research programs in history, the All of Us Research Program aims to create the largest and most diverse health research resource of its kind. Participants from all parts of the country share health information over time through surveys, electronic health records and more. Some participants also are invited to contribute blood and urine samples for analysis. Researchers will be able to use this data to learn more about how biology, behavior, and environment influence health and disease, which may lead to discoveries on how to further individualize health care in the future.
Over time, the program anticipates providing several kinds of information to participants, including: information on ancestry and traits, drug-gene interactions (pharmacogenomics) and genetic findings connected with high risk of certain diseases. Genomic results from All of Us, although produced at a high quality in specially certified labs, should be confirmed by a health care provider before a participant makes any changes to their care. The pharmacogenomic information may help participants work with their health care teams more effectively to make choices about certain prescription drugs. Genetic findings tied to 59 genes associated with risk of specific diseases, like breast cancer or heart disease, for which there are established medical guidelines for treatment or prevention will also be returned to participants. To ensure that the program uses the most current knowledge in the fast-moving field of clinical genetics, All of Us is following guidance from professional organizations such as the American College of Medical Genetics and Genomics and the Clinical Pharmacogenetics Implementation Consortium.
As health-related information is made available, all participants will have access to genetic counseling services from Color. A small percentage of people will have DNA results, such as a variation in the breast cancer gene BRCA1, that may be important for treatment or screening. This information can also be valuable to their immediate family members who may share the same genetic variant. For All of Us, that could amount to tens of thousands of participants out of its eventual 1 million. Color will deliver the results to these participants in genetic counseling sessions, highlighting any important findings they may want to discuss with a health care provider.
Color will offer educational materials and telecounseling in multiple languages, as well as access to in-house licensed clinical pharmacists who can help participants have more effective conversations with their health care providers. Genetic counselors will also be able to help connect participants to health care providers who can address their particular health risks. To help guide its genetic counseling services, Color’s steering committee is led by Amy Sturm, M.S., CGC, LGC, president of the National Society of Genetic Counselors. It also includes leadership of the American Board of Genetic Counseling. The steering committee will help ensure that Color delivers top-quality genetic counseling and serves as a platform for training future generations of genetic counselors. Color has built software and digital tools that remove traditional barriers to genetic counseling and clinical genetic testing. It has conducted more than 15,000 genetic counseling sessions to help people across the country understand their DNA information. For an overview of the outputs that Color will provide, watch this 90-second YouTube video featuring Eric Dishman, Director of the NIH All of Us Research Program.